Mersana - Aset Bersih saben Siji Saham MRSN

Mersana Therapeutics (MRSN) relies on the Dolaflexin platform to optimize ADC drug development costs. The consolidated book value per share confirms capital stability, with the metric recorded at -11.95. Stable demand for biotechnology protects the asset from recessions, while Martin Huber's flexible leadership focuses the strategy on leadership in female oncology therapy.

Mersana (MRSN) - Nilai Akuntansi saben Saham saka 04.07.2022 nganti 17.01.2026

Ringkesan rincian data analitis Mersana Therapeutics Inc (MRSN)

- rega lan prakiraan konsensus rega:

Bagan rega Mersana|MRSN - Target median analis

- data kapitalisasi pasar:

Nilai pasar Mersana Therapeutics, Inc.|MRSN - Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham Mersana Therapeutics|MRSN - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku mersana.com|MRSN - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Mersana Therapeutics|MRSN - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Mersana|MRSN - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Mersana Therapeutics, Inc.|MRSN - Utang jangka dawa|Utang jangka cendhak perusahaan Mersana Therapeutics

Analisis kabeh metrik perusahaan:mersana.com, MRSN

Produk asil prodhuksi Mersana Therapeutics Inc

Book value per share determines the portion of equity attributable to a single security through the difference between assets and liabilities. The book value trend for a single share of Mersana Therapeutics (MRSN) reflects the capitalization of the Dolaflexin platforms' intellectual property and the patent portfolio, confirming the material base of the biopharmaceutical business and the level of investment protection against sharp asset devaluation.

Analisis pesaing Mersana Therapeutics

Aset Bersih saben Siji Saham MRUS (Merus Corp)|IMMP: Aset Bersih saben Saham|Aset Bersih saben Siji Saham Anixa Biosciences, Inc.|atossatherapeutics.com (ATOS) - Ekuitas saben Saham|Nilai Buku saben Saham CNTX|Nilai Akuntansi saben Saham BriaCell Therapeutics Corp.|Nilai Buku saben Saham EPIX|Nilai Buku saben Saham QTI (QT Imaging, Inc.)